J & J ' s Stelara Succeeds in Ulcerative Colitis Study J & J ' s Stelara Succeeds in Ulcerative Colitis Study

Johnson& Johnson said on Tuesday its blockbuster drug Stelara (ustekinumab) was found to be effective in treating ulcerative colitis (UC) in a late-stage trial.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news